India's pharmaceutical industry, the backbone of global generic drug supply, is coming under pressure as the Iran war disrupts energy markets and trade routes.  India is the largest producer of generic drugs, which are cheaper pharmaceutical products made to match brand-name drugs in quality and performance as well as safety. The country's $50 billion (€46.44 billion) pharmaceutical sector supplies roughly 20% of global generic drug volumes, with more than half of its exports going to highly